Health
PSA Screening for Aggressive Prostate Cancer Supported in Men With Lynch Syndrome–Associated Pathogenic Variants – OncLive
Men carrying MSH2 and MSH6 pathogenic variants, which are associated with Lynch syndrome, were found to have a higher incidence…
Men carrying MSH2 and MSH6 pathogenic variants, which are associated with Lynch syndrome, were found to have a higher incidence of prostate cancer compared with age-matched non-carrier individuals, supporting the value of annual, targeted prostate-specific…
Continue Reading
-
Business18 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business15 hours agoDicker Data rides the AI trend to double digit growth
-
Business22 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News22 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’